Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis C news

Show

From To
Sofosbuvir/ledipasvir/ribavirin cures 100% of genotype 1 hepatitis C patients

An interferon-free regimen containing sofosbuvir (formerly GS-7997), ledipasvir (formerly GS-5885) and ribavirin produced a 12-week post-treatment sustained virological response (SVR12) rate of 100% for both treatment-naive hepatitis C

Published
05 March 2013
By
Liz Highleyman
Milk Thistle Drug May Help Control HCV Replication after Liver Transplant

Silibinin, a medication derived from the milk thistle plant, lowered hepatitis C virus (HCV) levels in patients awaiting liver transplantation in a pilot study, which may help reduce the risk of HCV recurrence in the new liver, Spanish researchers reported in the March 2013 Journal of Hepatology.

Published
02 March 2013
From
HIVandhepatitis.com
Health Canada Warns Of Serious Skin Reactions From Hepatitis C Drug

Two months after the FDA issued a safety alert informing about the serious skin reactions, some fatal, in patients taking Vertex Pharmaceuticals Inc.'s (VRTX: Quote) hepatitis C drug Incivek (telaprevir), it is now health Canada's turn to alert health-care providers and patients.

Published
01 March 2013
From
RTT News
HIV Accelerates Liver Fibrosis by Nearly a Decade Among People With Hep C

Fibrosis in those coinfected with hepatitis C and HIV is comparable in severity to that found in people mono- infected with hep C who are nearly a decade older.

Published
01 March 2013
From
Aidmeds
Addressing Hepatitis C Disparities in the African American Community

African Americans are twice as likely to be infected with the hepatitis C virus (HCV) compared to the general U.S. population, according to the CDC.

Published
01 March 2013
From
Google Alerts - Hepatitis
Pakistan: Low cost Hepatitis C treatment: ‘Everything is heading in the right direction – on paper’

The production of a local biosimilar version of interferon alfa is being delayed by bureaucratic obstacles, according to its developer.

Published
28 February 2013
From
Express Tribune
Pakistan: Hepatitis C patients get the axe as hospitals stop treatment

ISLAMABAD: Most public hospitals in twin cities have stopped providing treatment to Hepatitis patients who cannot afford to pay, putting their lives at stake.

Published
28 February 2013
From
The Express Tribune
Study shows value of hepatitis C therapy for HIV co-infected patients with compensated cirrhosis

Spanish research published in the online edition of Clinical Infectious Diseases shows the benefits of successful hepatitis C therapy for people co-infected with HIV who have compensated liver

Published
28 February 2013
By
Michael Carter
Hepatitis C Model Delivers Great Care Anywhere

Optimal HCV treatment for patients in a comprehensive health system requires an efficient and effective process. Ideally, the established structure would support rural as well as urban settings and allow for sharing of information, education of providers, and metrics to monitor treatments. Such a process was established successfully within the Department of VA.

Published
25 February 2013
From
Infectious Disease Special Edition
UNITAID can address HCV/HIV co-infection

In the first days of March, the governing body of UNITAID, the organisation financed mainly through a levy on air tickets, will decide on a new 4-year strategy. We believe UNITAID's new strategy should also include tackling a prevalent and serious, but curable, HIV co-morbidity: hepatitis C virus (HCV) infection.

Published
23 February 2013
From
The Lancet

Filter by country